| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| SLQTSelectQuote, Inc. | 293.87M | 1.67 | 125.56 | 15.5% | 3.95% | 11.28% | 0.72 | |
| GOCOGoHealth, Inc. | 38.62M | 2.40 | -3.64 | 8.74% | -26.96% | -0.64% | 1.15 |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Revenue | 226.21M | 539.5M | 877.35M | 1.06B | 631.67M | 734.67M | 798.89M |
| Revenue Growth % | - | 1.39% | 0.63% | 0.21% | -0.41% | 0.16% | 0.09% |
| Medical Costs & Claims | 79.58M | 169.55M | 199.2M | 239.34M | 187.67M | 158.96M | 130.61M |
| Medical Cost Ratio % | - | - | - | - | - | - | - |
| Gross Profit | 146.62M | 369.95M | 678.15M | 823.08M | 444M | 575.71M | 668.28M |
| Gross Margin % | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | 1.52% | 0.83% | 0.21% | -0.46% | 0.3% | 0.16% |
| Operating Expenses | 117.86M | 402.73M | 742.69M | 1.31B | 762.67M | 657.39M | 675.33M |
| OpEx / Revenue % | - | - | - | - | - | - | - |
| Depreciation & Amortization | 6.16M | 29.89M | 98.55M | 107.51M | 107M | 105.75M | 105.89M |
| Combined Ratio % | - | - | - | - | - | - | - |
| Operating Income | 28.76M | -32.78M | -64.55M | -489.45M | -318.67M | -81.68M | -7.05M |
| Operating Margin % | - | - | - | - | - | - | - |
| Operating Income Growth % | - | -2.14% | -0.97% | -6.58% | 0.35% | 0.74% | 0.91% |
| EBITDA | 34.92M | -2.89M | 34.01M | -381.94M | -211.66M | 24.07M | 98.84M |
| EBITDA Margin % | - | - | - | - | - | - | - |
| Interest Expense | 224K | 8.22M | 32.97M | 33.51M | 57.07M | 69.47M | 72.87M |
| Non-Operating Income | 379K | -79.21M | -358K | 11.27M | -115K | -37K | -74.86M |
| Pretax Income | 28.16M | 41.09M | -97.16M | -534.22M | -375.62M | -151.12M | -5.05M |
| Pretax Margin % | - | - | - | - | - | - | - |
| Income Tax | 46K | 22K | 43K | -24K | 764K | 154K | 2.27M |
| Effective Tax Rate % | - | - | - | - | - | - | - |
| Net Income | 28.12M | -41.07M | -44.27M | -189.36M | -148.71M | -63.26M | -2.93M |
| Net Margin % | - | - | - | - | - | - | - |
| Net Income Growth % | - | -2.46% | -0.08% | -3.28% | 0.21% | 0.57% | 0.95% |
| EPS (Diluted) | 1.34 | -1.96 | -3.30 | -26.85 | -17.72 | -7.19 | -0.66 |
| EPS Growth % | - | -2.46% | -0.68% | -7.14% | 0.34% | 0.59% | 0.91% |
| EPS (Basic) | 1.34 | -1.96 | -3.30 | -26.85 | -17.72 | -7.19 | -0.66 |
| Diluted Shares Outstanding | 20.91M | 20.91M | 5.61M | 7.07M | 8.45M | 9.29M | 9.98M |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Total Assets | 142.84M | 1.6B | 2.11B | 2.07B | 1.66B | 1.5B | 1.49B |
| Asset Growth % | - | 10.22% | 0.32% | -0.02% | -0.2% | -0.1% | -0.01% |
| Total Investment Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 54.03M | 143.77M | 391.82M | 429M | 414.56M | 476.44M | 400.41M |
| Cash & Equivalents | 505K | 12.28M | 144.23M | 84.36M | 16.46M | 90.81M | 40.92M |
| Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 0 | 0 | 3.4M | 0 | 57.59M | 49.17M | 34.64M |
| Goodwill & Intangibles | 0 | 1.17B | 1.08B | 594.67M | 500.61M | 396.55M | 302.5M |
| Goodwill | 0 | 386.55M | 386.55M | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 782.78M | 688.73M | 594.67M | 500.61M | 396.55M | 302.5M |
| PP&E (Net) | 11.78M | 6.34M | 17.35M | 47.73M | 46.77M | 48.84M | 48.64M |
| Other Assets | -65.81M | 282.85M | 624.34M | 997.45M | 697.36M | 577.74M | 736.88M |
| Total Liabilities | 329.49M | 742.15M | 709.64M | 1.18B | 1.07B | 1.04B | 1.03B |
| Total Debt | 5.01M | 291.65M | 400.57M | 696.29M | 557.42M | 543.05M | 527.97M |
| Net Debt | 4.5M | 279.38M | 256.34M | 611.93M | 540.96M | 452.24M | 487.05M |
| Long-Term Debt | 0 | 288.23M | 396.4M | 665.12M | 504.81M | 422.7M | 447.87M |
| Short-Term Debt | 4.86M | 3M | 4.17M | 5.27M | 5.27M | 75M | 39.5M |
| Total Current Liabilities | 47.98M | 113.06M | 127.37M | 217.07M | 265.45M | 370.01M | 338.05M |
| Accounts Payable | 28.87M | 69.58M | 8.73M | 144M | 137.17M | 144.97M | 113.36M |
| Deferred Revenue | 1.36M | 15.22M | 0 | 536K | 50.59M | 52.4M | 53.72M |
| Other Current Liabilities | 3.18M | 2.69M | 9.06M | 8.34M | 10.11M | 5.59M | 4.42M |
| Deferred Taxes | 226K | 243K | 0 | 0 | 0 | 0 | 1000K |
| Other Liabilities | 28K | 340.19M | 185.87M | 274.4M | 258.96M | 212.35M | 186.86M |
| Total Equity | -182.15M | 860.14M | 1.4B | 892.49M | 591.7M | 454.95M | 458.4M |
| Equity Growth % | - | 5.72% | 0.63% | -0.36% | -0.34% | -0.23% | 0.01% |
| Shareholders Equity | -186.65M | 860.14M | 380.42M | 353.1M | 318.06M | 280.32M | 294.8M |
| Minority Interest | 4.5M | 0 | 1.02B | 539.39M | 273.64M | 174.64M | 163.6M |
| Retained Earnings | -189.1M | 0 | -18.8M | -208.32M | -357.02M | -420.28M | -423.21M |
| Common Stock | 2.44M | 0 | 32K | 2K | 2K | 2K | 2K |
| Accumulated OCI | 14K | -17K | 17K | -59K | -144K | -127K | -151K |
| Return on Equity (ROE) | - | -0.12% | -0.04% | -0.17% | -0.2% | -0.12% | -0.01% |
| Return on Assets (ROA) | 0.2% | -0.05% | -0.02% | -0.09% | -0.08% | -0.04% | -0% |
| Equity / Assets | - | - | - | - | - | - | - |
| Debt / Equity | - | 0.34x | 0.29x | 0.78x | 0.94x | 1.19x | 1.15x |
| Book Value per Share | -8.71 | 41.14 | 249.29 | 126.31 | 70.07 | 48.96 | 45.93 |
| Tangible BV per Share | - | - | - | - | - | - | - |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Cash from Operations | 5.44M | -3K | -114.22M | -299.01M | 60.9M | 109.14M | -21.61M |
| Operating CF Growth % | - | -1% | -38071.33% | -1.62% | 1.2% | 0.79% | -1.2% |
| Operating CF / Revenue % | - | - | - | - | - | - | - |
| Net Income | 28.11M | -41.07M | -97.2M | -534.19M | -376.38M | -151.27M | -7.32M |
| Depreciation & Amortization | 6.16M | 32.98M | 98.55M | 107.51M | 107M | 105.75M | 105.89M |
| Stock-Based Compensation | 0 | 0 | 216.23M | 27.3M | 27.14M | 19.55M | 11.28M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 4.48M |
| Other Non-Cash Items | 791K | 159.25M | 20.44M | 406.8M | 32.98M | 19M | -61.04M |
| Working Capital Changes | -29.62M | -151.17M | -352.24M | -306.42M | 270.16M | 116.12M | -74.9M |
| Cash from Investing | -6.17M | -815.61M | -14.52M | -19.8M | -13.51M | -13.73M | 3.81M |
| Capital Expenditures | -6.17M | -8.02M | -14.52M | -19.8M | -13.51M | -13.73M | -13.73M |
| Acquisitions | 0 | -807.59M | 0 | 0 | 0 | 0 | 17.54M |
| Purchase of Investments | 0 | 0 | -508.32M | 0 | 0 | 0 | 0 |
| Sale/Maturity of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing | 0 | 0 | 508.32M | 0 | 0 | 0 | 0 |
| Cash from Financing | 63K | 827.43M | 260.66M | 259.09M | -115.05M | -21.11M | -32.03M |
| Dividends Paid | 0 | 0 | -400K | 0 | 0 | -3.57M | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | -345K | -2.29M | -1.51M |
| Stock Issued | 0 | 541.26M | 862.41M | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | 142K | 1000K | 1000K | 1000K | -1000K | -1000K | 1000K |
| Other Financing | -79K | 0 | -614.17M | -6.62M | -4.33M | 91K | -32.73M |
| Net Change in Cash | -667K | 11.77M | 131.96M | -59.87M | -67.9M | 74.34M | -49.89M |
| Exchange Rate Effect | -3K | -49K | 35K | -155K | -238K | 42K | -55K |
| Cash at Beginning | 1.17M | 505K | 12.28M | 144.23M | 84.36M | 16.46M | 90.81M |
| Cash at End | 505K | 12.28M | 144.23M | 84.36M | 16.46M | 90.81M | 40.92M |
| Free Cash Flow | -727K | -8.02M | -128.74M | -318.81M | 47.39M | 95.41M | -35.34M |
| FCF Growth % | - | -10.03% | -15.05% | -1.48% | 1.15% | 1.01% | -1.37% |
| FCF Margin % | - | - | - | - | - | - | - |
| FCF per Share | -0.03 | -0.38 | -22.94 | -45.12 | 5.61 | 10.27 | -3.54 |
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Combined Ratio | 87.28% | 106.08% | 107.36% | 146.07% | 150.45% | 111.12% | 100.88% |
| Medical Cost Ratio | 35.18% | 31.43% | 22.7% | 22.53% | 29.71% | 21.64% | 16.35% |
| Return on Equity (ROE) | - | -12.11% | -3.92% | -16.53% | -20.04% | -12.09% | -0.64% |
| Return on Assets (ROA) | 19.68% | -4.71% | -2.39% | -9.07% | -7.98% | -4.01% | -0.2% |
| Equity / Assets | -127.52% | 53.68% | 66.35% | 43.14% | 35.66% | 30.34% | 30.8% |
| Book Value / Share | -8.71 | 41.14 | 249.29 | 126.31 | 70.07 | 48.96 | 45.93 |
| Debt / Equity | - | 0.34x | 0.29x | 0.78x | 0.94x | 1.19x | 1.15x |
| Revenue Growth | - | 138.5% | 62.62% | 21.09% | -40.54% | 16.31% | 8.74% |
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Commission | 671.14M | 881.26M | 341.47M | - | 515.72M |
| Commission Growth | - | 31.31% | -61.25% | - | - |
| Medicare | - | - | - | 715.6M | - |
| Medicare Growth | - | - | - | - | - |
| Other Revenue | - | - | - | 19.07M | - |
| Other Revenue Growth | - | - | - | - | - |
| Enterprise | 206.21M | 181.15M | 290.21M | - | - |
| Enterprise Growth | - | -12.15% | 60.20% | - | - |
| Partner Marketing And Enrollment Services | 164.75M | 131.34M | 133.13M | - | - |
| Partner Marketing And Enrollment Services Growth | - | -20.28% | 1.36% | - | - |
| Direct Partner Campaigns | 31.9M | 47.34M | 44.77M | - | - |
| Direct Partner Campaigns Growth | - | 48.42% | -5.44% | - | - |
| Enterprise, Other | 9.56M | 2.47M | 4.97M | - | - |
| Enterprise, Other Growth | - | -74.20% | 101.58% | - | - |
| Ancillary | 4.73M | 3.49M | 3.12M | - | - |
| Ancillary Growth | - | -26.16% | -10.60% | - | - |
| Small Group | 785K | 133K | 213K | - | - |
| Small Group Growth | - | -83.06% | 60.15% | - | - |
GoHealth, Inc. (GOCO) grew revenue by 8.7% over the past year. This is steady growth.
GoHealth, Inc. (GOCO) reported a net loss of $199.0M for fiscal year 2024.
GoHealth, Inc. (GOCO) has a return on equity (ROE) of -0.6%. Negative ROE indicates the company is unprofitable.
GoHealth, Inc. (GOCO) has a combined ratio of 100.9%. A ratio above 100% means claims and expenses exceed premiums.